20 21 Ducks usually show little or no clinical signs following highly pathogenic avian 22
influenza virus infection. In order to analyze if the gut microbiota could 23 contribute to the control of influenza virus replication in ducks, we used a broad-24 spectrum oral antibiotic treatment to deplete the gut microbiota before infection 25 with a highly pathogenic H5N9 avian influenza virus. Antibiotic-treated ducks 26 and non-treated control ducks did not show any clinical signs following H5N9 27 virus infection. We did not detect any difference in virus titers neither in the 28 respiratory tract, nor in the brain and spleen. However, we found that antibiotic-29 treated H5N9 virus infected ducks had significantly increased intestinal virus 30 excretion at day 3 and 5 post-infection. This was associated with a significantly 31 decreased antiviral immune response in the intestine of antibiotic-treated ducks. 32
Our findings highlight the importance of an intact microbiota for an efficient 33 control of avian influenza virus replication in ducks. Ducks have a central role in the epidemiology of influenza virus (1, 2) . They have 54 been shown to shed viruses belonging to multiple subtypes and represent the 55 main reservoir of influenza viruses that can occasionally be transmitted to other 56 animal species, including gallinaceous poultry, and occasionally mammals. Low 57 pathogenic avian influenza viruses (LPAIVs) of the H5 and H7 subtype have the 58 capacity to evolve to highly pathogenic avian influenza viruses (HPAIV). This 59 evolution is due to the acquisition of a polybasic cleavage site at the 60 hemagglutinin (HA) cleavage site, allowing the HA to be cleaved by intracellular 61 ubiquitous proteases and the virus to spread systematically (3). By contrast, the 62 HA of LPAIV is proteolytically matured by trypsin-like proteases expressed in the 63 respiratory and digestive tract, thus restricting replication of LPAIV to these 64 tissues in birds. 65
In chickens, HPAIV infection can reach 100% mortality in a few days, whereas 66 ducks usually only exhibit mild clinical signs, if any, following HPAIV infection 67 (4). The mechanisms contributing to the host species-dependent differences in 68 pathogenicity are not fully understood. Ducks express the viral RNA sensor 69 retinoic acid-induced gene I (RIG-I), which is absent from chickens (5). 70
Melanoma differentiation-associated protein 5 (MDA-5) could compensate for 71 the lack of RIG-I in chickens cells and mediate type I IFN responses to influenza A 72 virus infection (6). However, comparative studies have provided evidence that 73 HPAIV infections are associated with a more rapid type I interferon immune 74 response in ducks compared to chickens and reduced pro-inflammatory 75 cytokines expression in ducks compared to chickens. This may lead to reduced 76 immunopathology and therefore less clinical signs in ducks (7-11). Extensive 77 tissue damage due to higher levels of viral replication and inflammation in 78 multiple organs are probably the cause of the higher HPAIV-associated mortality 79 in chickens compared to ducks. 80
The gut microbiota is now recognized as a regulator of many physiological 81 functions in the host, reaching far beyond its contribution to digestion (12). 82
Several studies have highlighted the role of the gut microbiota in shaping the 83 antiviral immune response against influenza virus, in mammals, in which the 84 virus replicates in the respiratory tract (13) (14) (15) (16) (17) , as well as following LPAIV 85 infection in chickens, in which the virus replicates in the respiratory and 86 digestive tract (18, 19) . 87
Altogether, these observations prompted us to investigate to what extent the gut 88 microbiota could contribute to the control of HPAIV infection in ducks. By 89 treating ducks with a broad-spectrum antibiotic (ABX) cocktail, we achieved a 90 significant depletion of the intestinal microbiota. Groups of non-treated and ABX-91 treated ducks were infected with a H5N9 HPAIV. We revealed that ABX-treated 92 ducks had significantly higher viral excretion in the intestine, which correlated 93 with an impaired antiviral immune response. This study thus demonstrates that 94 the intestinal microbiota contributes to the control of avian virus replication in 95 ducks. 96
RESULTS 98 99
Antibiotic treatment leads to a significant depletion of the intestinal 100 microbiota 101
From two weeks of age, ABX-treated ducks were continuously treated with a 102 broad-spectrum ABX cocktail though their drinking water ( Fig. 1A) . To assess the 103 impact of the ABX-treatment on the intestinal microbiota, we determined the 104 bacterial load from fresh feces harvested from non-treated control ducks and 105 from ABX-treated ducks. After two weeks of ABX-treatment, we detected a 106 greater than 10 6 -fold depletion of the intestinal bacteria cultivable under aerobic 107 conditions ( Fig. 1B) , as well as a greater than 10 2 -fold depletion of the number of 108 bacterial 16S rRNA gene copies (Fig. 1C ). Using 16S rRNA FISH, we detected 109 bacteria aggregating as filaments in the vicinity of intestinal epithelial cells on 110 ileal tissue section from non-treated control ducks ( Fig. 1D ). In contrast, no 111 bacteria were detected by FISH in ileal samples originating from ABX-treated 112 ducks. Based on the culture method and culture independent methods, we can 113 thus conclude that the ABX treatment caused a significant reduction in the ducks' 114 gut microbiota. The ABX treatment did not induce any clinical signs or change in 115 the ducks' behavior, nor did it diminish the quantity of water consumed. There 116 was no significant difference in the average weight of the ABX-treated and the 117 non-treated animals (data not shown). 118 119
Impact of intestinal microbiota depletion on influenza virus replication 120
We inoculated ducks via the ocular, nasal and tracheal route with 3. We evaluated the level of virus excretion by quantifying viral nucleic acids by 126 RT-qPCR from tracheal and cloacal swabs. Tracheal shedding was equivalent 127 between non-treated and ABX-treated ducks ( Fig. 2A ). By contrast, cloacal 128 shedding was higher in ABX-treated animals at 3 and 5 days post infection (dpi), 129 with a hundred-fold difference at 3 dpi ( Fig. 2B ). 130
We then analyzed viral load in organs harvested from animals autopsied at 3 and 131 7dpi. Viral nucleic acid was detected in the brain and in the spleen of infected 132 animals, as expected with a HPAIV, with no difference observed between ABX-133 treated-ducks and non-treated ducks (data not shown). In the lungs and ileum, 134 viral nucleic acid load was increased in ABX-treated-ducks compared to non-135 treated ducks at 3 dpi ( Fig. 2C&D ), but the differences did not reach statistical 136 significance. Finally, we measured infectious virus particles from fresh feces 137 collected from individual ducks at 3 dpi. We detected a significantly higher 138 number of infectious virus particles in feces from ABX-treated-ducks compared 139 to non-treated ducks ( Fig. 2E ), thus confirming that ABX-induced depletion of 140 the intestinal microbiota is associated with an increase of influenza virus fecal 141 shedding in ducks. 142 143
Impact of intestinal microbiota depletion on the respiratory and intestinal 144 epithelia 145
Histopathological analysis performed at 3 and 7 dpi revealed a diffuse to 146 multifocal subacute tracheitis in ducks infected with H5N9 virus, which was 147 equivalent in ABX-treated and non-treated animals. Inflammatory cellular 148 infiltrates in the lamina propria were variably composed of mononuclear cells 149 (lymphocytes, plasmocytes and macrophages) and a few heterophils. We 150 observed mild focal necrosis and exfoliation of the superficial mucosal 151 epithelium, associated with loss of ciliature and regenerative epithelial 152 hyperplasia. Histological scores were low for infected animals, yet different from 153 non-infected animals ( Fig. 3A ). Immunohistochemically, viral antigen was 154 detected in epithelial cells of the trachea, similarly in ABX-treated and non-155 treated ducks infected with H5N9 virus (Fig. 3B ). In the ileum, we did not detect 156 significant lesions associated neither with ABX-treatment nor H5N9 infection 157 (data not shown). Viral antigen was detected in differentiated epithelial cells of 158 the ileum, as well as in desquamated cells in the intestinal lumen ( Fig. 3C ). 159
To gain further insight into the potential consequences of increased intestinal 160 replication of H5N9 associated with depletion of the bacterial flora, we analyzed 161 the expression of tight junction genes on ileal samples. We observed a significant 162 increase in Claudin-1 mRNA levels in ducks infected with H5N9 at 3 dpi.
However, this increase of Claudin-1 mRNA expression was abrogated in H5N9-164 infected ducks treated with ABX ( Fig. 4A ). Similar results were obtained with 165 Zonula occludens-1, another tight junction gene, for which a twofold non-166 statistically significant upregulation was observed specifically in non-treated 167 H5N9 infected ducks at 3dpi ( In the ileum, we did not detect significant upregulation of interferon-α (IFN-α) or 196 IFN-β mRNA expression in ducks infected with HPAIV, regardless of the status of 197 the intestinal microbiota ( Fig. 6B ). However, we observed an upregulation of 198 type I IFN-induced genes in non-infected ABX-treated ducks ( Fig. 6B ), but the 199 differences did not reach statistical significance. Interestingly, type I IFN-induced 200 genes expression was significantly reduced at 3 dpi in H5N9-infected ABX-201 treated ducks compared to H5N9-infected non-treated ducks (Fig. 6B ). 202
In order to evaluate if microbiota depletion could affect the antiviral humoral 203 response in the intestine, we quantified the IgA expression levels in intestinal 204 samples. We observed strongly reduced IgA heavy chain constant region mRNA 205 expression in the intestine of ABX-treated ducks, regardless of the H5N9 206 infection status ( Fig. 7A ). We next analyzed the anti-H5 immunoglobulins levels 207 in fecal samples that were available from non-infected ducks, as well as from 208 H5N9-infected ducks at 3 dpi. We detected an increase in the anti-H5 209 immunoglobulins levels in feces collected from H5N9-infected non-treated ducks 210 at 3 dpi, while no increase was observed in H5N9-infected ABX-treated ducks 211 The contribution of the gut microbiota to the control of influenza virus 234 replication has been studied in mice, as well as in chickens infected with a LPAIV 235 (13, 14, (16) (17) (18) (19) 23) . How the gut microbiota modulates HPAIV infection, or more 236 generally influenza virus infection in ducks has to our knowledge never been 237 investigated. Here we provide evidence that ABX-mediated depletion of the 238 intestinal microbiota caused an increase in H5N9 HPAIV replication in the 239 digestive tract of ducks and was associated with a reduction of the antiviral 240 immune response in the intestine. Similar results were observed in the digestive 241 tract of chickens infected with a LPAIV (18, 19). Depletion of the gut microbiota 242 in mice and chicken was associated with an increase in influenza virus 243 replication in the respiratory tract (13, 14, 18, 19) . By contrast, we did not detect 244 a significant increase in influenza virus replication in the respiratory tract of 245 ducks suggesting that this difference could be due to the viral strain used or host 246
factors. 247
Upon depletion of the gut microbiota with ABX, we observed a reduction of the 248 type I IFN-induced gene expression, as well as a reduction of the humoral 249 response in the intestine following influenza virus infection. The gut microbiota 250 has been shown to stimulate the immune response to pathogens most likely 251 through the constant low-level exposure of epithelial cells and immune cells 252 present in the intestinal mucosa to microbiota-derived pathogen-associated 253 molecular patterns, as well as to microbial metabolites (23-26). This constant 254 low-level stimulation is thought to maintain the immune system in an optimal 255 state of reactivity allowing it to respond to pathogens via a timely innate and 256 adaptive immune response (17, 27, 28) . In particular, the microbiota is required 257 for IgA production in the intestine (29, 30). Table. 1) in 96-well plates according to the manufacturer instructions 398 (OneStep RT-PCR, Qiagen, Toronto, Canada). Absolute quantification was 399 performed using a standard curve based on a 10-fold serial dilution of a plasmid 400 containing the A/Guinea Fowl/129/2015(H5N9) M gene. EID 50 was determined 401 by diluting 0.1g of feces into 100µl PBS containing antibiotics: vancomycin 402 (500mg/l), neomycin (500mg/l), metronidazole (500mg/l), ampicillin (1g/l) and 403 colistin (80mg/l) to avoid bacterial growth. We had first verified that the 404 antibiotics did not inhibit viral replication in embryonated chicken eggs. Samples 405 were centrifuged at 1000g at 4°C for 2min to pellet debris and supernatants 406 were diluted in antibiotic-complemented PBS with a 10x dilution factor. For each 407 sample, 100µl were injected in three 10-day-old SPF embryonated chicken eggs, 408 which were incubated for 72h before allantoic fluids were harvested. Presence of 409 virus was revealed by a hemagglutination test. 410
411

RNA extraction from tissue samples and complementary DNA synthesis
For each organ, 30 mg of tissue were placed in tubes with beads (Precellys lysis 413 kit, Stretton Scientific Ltd, Stretton, UK) filled with 600µl of TRIzol reagent 414 (Invitrogen, Carlsbad, CA, USA) and mixed for 30s at 6800 rpm three times in a 415 bead beater (Precellys 24®, Bertin Technologies, Montigny-leBretonneux, 416 France). Following TRIzol extraction, the aqueous phase was transferred to RNA 417 extraction column and prcossed according to the manufacturer's instructions 418 (NucloeSpin RNA, Macherey-Nagel GmbH&Co, Germany). cDNA was synthesized 419 by reverse transcription of 500ng of total RNA using both oligo(dT) 18 
